The Role of Native T1 and T2 Mapping Times in Identifying PD-L1 Expression and the Histological Subtype of NSCLCs.
Chandra BortolottoGaia MessanaAntonio Lo TitoGiulia Maria StellaAlessandra PintoChiara PodreccaRiccardo BellazziAlessia GerbasiFrancesco AgustoniFei HanMarcel Dominik NickelDomenico ZacàAndrea Riccardo FilippiOlivia Maria BottinelliLorenzo PredaPublished in: Cancers (2023)
We investigated the association of T1/T2 mapping values with programmed death-ligand 1 protein (PD-L1) expression in lung cancer and their potential in distinguishing between different histological subtypes of non-small cell lung cancers (NSCLCs). Thirty-five patients diagnosed with stage III NSCLC from April 2021 to December 2022 were included. Conventional MRI sequences were acquired with a 1.5 T system. Mean T1 and T2 mapping values were computed for six manually traced ROIs on different areas of the tumor. Data were analyzed through RStudio. Correlation between T1/T2 mapping values and PD-L1 expression was studied with a Wilcoxon-Mann-Whitney test. A Kruskal-Wallis test with a post-hoc Dunn test was used to study the correlation between T1/T2 mapping values and the histological subtypes: squamocellular carcinoma (SCC), adenocarcinoma (ADK), and poorly differentiated NSCLC (PD). There was no statistically significant correlation between T1/T2 mapping values and PD-L1 expression in NSCLC. We found statistically significant differences in T1 mapping values between ADK and SCC for the periphery ROI ( p -value 0.004), the core ROI ( p -value 0.01), and the whole tumor ROI ( p -value 0.02). No differences were found concerning the PD NSCLCs.
Keyphrases
- high resolution
- high density
- small cell lung cancer
- magnetic resonance imaging
- end stage renal disease
- advanced non small cell lung cancer
- computed tomography
- mass spectrometry
- magnetic resonance
- young adults
- small molecule
- peritoneal dialysis
- cell therapy
- contrast enhanced
- human health
- locally advanced
- binding protein
- deep learning